Stem Cells

Global Market Trajectory & Analytics

MCP-6142

EXECUTIVE ENGAGEMENTS

POOL

4144
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

746
Interactions with Platform & by Email

PARTICIPANTS

124
Unique # Participated

VALIDATIONS

36
Responses Validated*

COMPANIES

233
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

66

PAGES

329

EDITION

16

PRICE

USD 5600

CODE

MCP-6142


COMPETITIVE METRICS

COMPANY

D S N T

% *

123Genetix

Login Required

3D Biotek, LLC

Login Required

3D Spine Matrix Biotechnology

Login Required

A.K. Traders Ltd

Login Required

ABR--Affinity BioReagents

Login Required

Accellta

Login Required

ActiJoint

Login Required

Adaptive BioScience, Inc.

Login Required

AdiCyte

Login Required

Adipogen International

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 233 COMPETITORS

Login to access data silos

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.
The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

SELECT PLAYERS

apceth Biopharma GmbH; Athersys Inc.; AVIVA BioSciences Corporation; BioE Inc.; Bone Therapeutics SA; Cesca Therapeutics Inc.; Cryo-Cell International Inc.; Cytori Therapeutics Inc.; ESI BIO; Gamida Cell Ltd.; Holostem Terapie Avanzate; International Stem Cell Corp.; Kangstem Biotech. Ltd.; Lonza Group Ltd.; Mesoblast Ltd.; Neuralstem Inc.; Nuvasive Inc.; OncoMed Pharmaceuticals Inc.; Osiris Therapeutics Inc.; Promethera Biosciences S.A.N.V; Reliance Life Sciences; ReNeuron Group Plc.; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Stempeutics Research Pvt. Ltd.; Takara Bio USA Inc.; TiGenix NV; U.S Stem Cell Inc.; ViaCord

SEGMENTS

» Product Type (Adult Stem Cells, Other Product Types) » Application (Regenerative Medicine, Drug Discovery & Development)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
Recent Market Activity
Select Approved Stem Cell Products
Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
Trends Related to Stem Cell Clinical Trials
Select Stem Cell Pipeline Analysis
Current & Future Analysis
Stem Cell Research Funding Policies across the World
Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
Dental Mesenchymal Stem Cells - Emergence of a Niche Market
For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
2. FOCUS ON SELECT PLAYERS
Athersys, Inc. (USA)
Apceth GmbH & Co.KG (Germany)
AVIVA BioSciences Corporation (USA)
BioE, Inc. (USA)
Bone Therapeutics SA (Belgium)
Cesca Therapeutics, Inc. (USA)
Cryo-Cell International, Inc. (USA)
Cytori Therapeutics, Inc. (USA)
ESI BIO, a Division of BioTime Inc. (USA)
Gamida Cell Ltd. (Israel)
Holostem Terapie Avanzate (Italy)
International Stem Cell Corporation (USA)
Kangstem Biotech., Ltd. (Korea)
Lonza Group Ltd (Switzerland)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (USA)
Nuvasive, Inc. (USA)
Osiris Therapeutics, Inc. (USA)
OncoMed Pharmaceuticals, Inc (USA)
PROMETHERA Biosciences S.A.N.V (Belgium)
Reliance Life Sciences (India)
ReNeuron Group Plc. (UK)
STEMCELL Technologies, Inc. (Canada)
Stemedica Cell Technologies, Inc (USA)
Stempeutics Research Pvt. Ltd. (India)
Takara Bio USA Inc (USA)
TiGenix NV (Belgium)
U.S Stem Cell, Inc. (USA)
ViaCord, LLC (USA)
3. MARKET TRENDS & DRIVERS
Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
Embryonic Stem Cell Gene Nanog Found to Reverse Aging
Canadian and Dutch Scientists Finds the “Genetic Switch” to Increase Stem Cell Volume from Cord Blood
The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
Adverse Reactions of Stem Cell-Face Lift Therapy
Stem Cell-Breast Enhancement
Other Innovations Using Stem Cells
New Stem Cell Software & Products
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
USA Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Canada Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Japan Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
China Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
France Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Germany Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Italy Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
UK Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2020 & 2027
Rest of World Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2020 & 2027
Total Companies Profiled: 233

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com